<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
      <actionDate>2015-05-22</actionDate>
    </latestAction>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <amendments />
    <relatedBills>
      <item>
        <latestTitle>21st Century Cures Act</latestTitle>
        <number>6</number>
        <latestAction>
          <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
          <actionDate>2015-07-13</actionDate>
        </latestAction>
        <type>HR</type>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <billNumber>2438</billNumber>
    <updateDate>2016-11-02T22:08:06Z</updateDate>
    <cboCostEstimates />
    <sponsors>
      <item>
        <fullName>Rep. Collins, Chris [R-NY-27]</fullName>
        <firstName>Chris</firstName>
        <district>27</district>
        <lastName>Collins</lastName>
        <byRequestType />
        <identifiers>
          <lisID>2151</lisID>
          <gpoId />
          <bioguideId>C001092</bioguideId>
        </identifiers>
        <middleName />
        <party>R</party>
        <state>NY</state>
        <bioguideId>C001092</bioguideId>
      </item>
    </sponsors>
    <notes />
    <originChamber>House</originChamber>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <cosponsors />
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. COLLINS of New York:H.R. 2438.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the US Constitution[Page H3389]</pre>]]></constitutionalAuthorityStatementText>
    <calendarNumbers />
    <committeeReports />
    <billType>HR</billType>
    <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to broader application of Bayesian statistics and adaptive trial designs.</title>
    <introducedDate>2015-05-19</introducedDate>
    <actions>
      <actionTypeCounts>
        <placeholderTextForH>1</placeholderTextForH>
        <introducedInTheHouse>1</introducedInTheHouse>
        <billReferrals>1</billReferrals>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2015-05-22</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <links />
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <actionCode>H11100</actionCode>
        <actionDate>2015-05-19</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <links />
        <committee />
        <actionCode>Intro-H</actionCode>
        <actionDate>2015-05-19</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <links />
        <committee />
        <actionCode>1000</actionCode>
        <actionDate>2015-05-19</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
    </actions>
    <congress>114</congress>
    <summaries>
      <billSummaries>
        <item>
          <actionDate>2015-05-19</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <lastSummaryUpdateDate>2015-07-10T18:40:45Z</lastSummaryUpdateDate>
          <versionCode>00</versionCode>
          <updateDate>2015-05-19T04:00:00Z</updateDate>
          <name>Introduced in House</name>
          <text><![CDATA[<p>This bill requires the Food and Drug Administration to issue guidance that addresses using alternative statistical methods, including adaptive trial design and Bayesian methods, in clinical trials and in the development and review of drugs and biological products.</p>]]></text>
        </item>
      </billSummaries>
    </summaries>
    <laws />
    <createDate>2015-05-20T08:46:22Z</createDate>
    <titles>
      <item>
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to broader application of Bayesian statistics and adaptive trial designs.</title>
        <chamberCode />
      </item>
      <item>
        <chamberName />
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to broader application of Bayesian statistics and adaptive trial designs.</title>
        <chamberCode />
      </item>
    </titles>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2015-05-19T14:04:10Z</date>
            </item>
          </activities>
          <type>Standing</type>
          <chamber>House</chamber>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2015-05-22T15:11:33Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
        </item>
      </billCommittees>
    </committees>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

